The purpose of the follow-up study is to continue measuring the impact of the pandemic on regulatory organizations from several dimensions compared to our base research in the fall of 2019. This survey requires an individual response (not a company consensus) and should take no more than 10 minutes to complete.
The research from our fall 2020 Covid-19 Regulatory Impact study focused on both short- and long-term regulatory impact to regulatory organizations and how they were responding to all the sudden changes. We learned how companies were adapting and explored the many shifts in the ways of working from over 250+ individuals from 50+ companies that participated in the study.
- Shifts in strategies and priorities in the regulatory organization (past 12 months) (How did companies adapt?)
- Planned vs actual implementations in the past 12-18 months (What did companies adopt?)
- Evolution of Team Effectiveness with new ways of working (What can normal look like?)
The survey will launch on February 14th, 2022, and close on April 20th, 2022. Results will be available by the end of May 2022. As with all our studies, the data is blinded, there is no fee to participate, and you get the full study results. Private debriefs will be provided for Gens and Associates Members and a general community debrief for all other participating organizations.
Take the COVID-19 Study (<10 minutes)
(Select version that best describes your organization)
Join our Benchmark Community Distribution List
Survey Team
We have a very talented research team to support this study
Katherine Yang-Iott is a core member of the Gens and Associates team with over 15 years of experience in the healthcare and pharmaceutical industry leading and managing complex interdisciplinary projects. She worked as a research scientist at Regeneron Pharmaceuticals and The Children’s Hospital of Philadelphia before transitioning to consulting work, where she focused on strategy development, change management and continuous improvement projects to support research operations.
Katherine has a Master’s of Science in Organizational Dynamics from the University of Pennsylvania and a Bachelor’s of Science in Biochemistry. Katherine can be reached at kyang-iott@gens-associates.com.
Steve Gens is the survey co-founder with the first industry survey conducted in 2007. The 2018 World Class RIM follow-up will be the 33rd survey conducted under Steve’s leadership. He has over 30 years of business experience with the majority in the biopharmaceutical and healthcare industries. His early career was spent at Johnson and Johnson and then moved into consulting where he managed several healthcare consulting practices for Booz Allen Hamilton and First Consulting Group.
Steve has deep experience in strategy formulation and implementation, organization development and performance, industry benchmarking, information management strategy, and facilitating strategic change. He consults for many large global biopharmaceutical companies and with small high growth organizations. He has a Master of Science in Organization Development from American University with distinction for his field work and a BS in Business Computer Science. Steve is a frequent speaker and was named as one of the 2017 PharmaVoice 100 for his contributions to industry.